SPG11 Peptide | 5015P

SPG11 Peptide | 5015P | Gentaur UK, US & Europe Distribution

Short Description: (CT) SPG11 peptide

Species: Human

Location: 15 amino acids near the carboxy terminus of human SPG11.

Tested Application: Bl

Application: SPG11 peptide is used for blocking the activity of SPG11 antibody.

Physical State: Liquid

Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

Concentration: 200 ug/mL

Storage: Store SPG11 peptide at -20˚C, stable for one year.

NCBI Official Symbol: SPG11

Alternate Names: KIAA1840, KIAA1840, Spatacsin, Colorectal carcinoma-associated protein

NCBI Gene ID: 80208

User Note: N/A

NCBI Official Name: Spastic Paraplegia 11 (Autosomal Recessive)

Background: Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nature Gen. 2007; 39:366-372.

Disclaimer: This product is for research use only.